North America Over the Counter Drugs Market - Forecasts from 2018 to 2023
The North America over-the-counter market was valued at US$43.341 billion in 2017 and is projected to expand at a CAGR of 4.24% over the forecast period to reach US$55.618 billion by 2023. Over the counter drugs are those drugs that are available to the consumers without the prescription. The high frequency of occurrences for many of the symptoms for which the over the counter medicines are required is driving the growth of the market. Moreover, the ability to provide convenience value along with growing disposable income is further supplementing the growth of the market.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in key countries. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the over the counter drugs value chain. Last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the North America over the counter drugs market.
Major industry players profiled as part of the report are Sanofi, GlaxoSmithKline PLC, Pfizer Inc., and Bayer AG others.
Segmentation
The North America over the counter drugs market has been analyzed through following segments:
By Products
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in key countries. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the over the counter drugs value chain. Last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the North America over the counter drugs market.
Major industry players profiled as part of the report are Sanofi, GlaxoSmithKline PLC, Pfizer Inc., and Bayer AG others.
Segmentation
The North America over the counter drugs market has been analyzed through following segments:
By Products
- Cough, Cold, and Flu Products
- Analgesics
- Dermatology Products
- Gastrointestinal Products
- Oral Healthcare Products
- Weight-loss/Dietary Products
- Opthalmic Products
- Sleep Aids
- Others
- Oral
- Topical
- Parenteral
- United States
- Canada
- Mexico
- Others
1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. NORTH AMERICA OVER THE DRUGS MARKET BY PRODUCTS
5.1. Cough, Cold, and Flu Products
5.2. Analgesics
5.3. Dermatology Products
5.4. Gastrointestinal Products
5.5. Oral Health Products
5.6. Weight-Loss/Dietary Products
5.7. Opthalmic Products
5.8. Sleep Aids
5.9. Others
6. NORTH AMERICA OVER THE COUNTER DRUGS MARKET BY MODE OF ADMINISTRATION
6.1. Oral
6.2. Topical
6.3. Parenteral
7. NORTH AMERICA OVER THE COUNTER DRUGS MARKET BY COUNTRIES
7.1. United States
7.2. Canada
7.3. Mexico
7.4. Others
8. COMPETITIVE INTELLIGENCE
8.1. Market Share Analysis
8.2. Recent Deals and Investment
8.3. Strategies of Key Players
9. COMPANY PROFILES
9.1. Sanofi
9.1.1. Company Overview
9.1.2. Financials
9.1.3. Products and Services
9.1.4. Recent Developments
9.2. Johnson & Johnson Inc.
9.2.1. Company Overview
9.2.2. Financials
9.2.3. Products and Services
9.2.4. Recent Developments
9.3. Novartis AG
9.3.1. Company Overview
9.3.2. Financials
9.3.3. Products and Services
9.3.4. Recent Developments
9.4. Pfizer, Inc.
9.4.1. Company Overview
9.4.2. Financials
9.4.3. Products and Services
9.4.4. Recent Developments
9.5. GlaxoSmithKline PLC
9.5.1. Company Overview
9.5.2. Financials
9.5.3. Products and Services
9.5.4. Recent Developments
9.6. PGT Healthcare
9.6.1. Company Overview
9.6.2. Financials
9.6.3. Products and Services
9.6.4. Recent Developments
9.7. Takeda Pharmaceutical Company
9.7.1. Company Overview
9.7.2. Financials
9.7.3. Products and Services
9.7.4. Recent Developments
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. NORTH AMERICA OVER THE DRUGS MARKET BY PRODUCTS
5.1. Cough, Cold, and Flu Products
5.2. Analgesics
5.3. Dermatology Products
5.4. Gastrointestinal Products
5.5. Oral Health Products
5.6. Weight-Loss/Dietary Products
5.7. Opthalmic Products
5.8. Sleep Aids
5.9. Others
6. NORTH AMERICA OVER THE COUNTER DRUGS MARKET BY MODE OF ADMINISTRATION
6.1. Oral
6.2. Topical
6.3. Parenteral
7. NORTH AMERICA OVER THE COUNTER DRUGS MARKET BY COUNTRIES
7.1. United States
7.2. Canada
7.3. Mexico
7.4. Others
8. COMPETITIVE INTELLIGENCE
8.1. Market Share Analysis
8.2. Recent Deals and Investment
8.3. Strategies of Key Players
9. COMPANY PROFILES
9.1. Sanofi
9.1.1. Company Overview
9.1.2. Financials
9.1.3. Products and Services
9.1.4. Recent Developments
9.2. Johnson & Johnson Inc.
9.2.1. Company Overview
9.2.2. Financials
9.2.3. Products and Services
9.2.4. Recent Developments
9.3. Novartis AG
9.3.1. Company Overview
9.3.2. Financials
9.3.3. Products and Services
9.3.4. Recent Developments
9.4. Pfizer, Inc.
9.4.1. Company Overview
9.4.2. Financials
9.4.3. Products and Services
9.4.4. Recent Developments
9.5. GlaxoSmithKline PLC
9.5.1. Company Overview
9.5.2. Financials
9.5.3. Products and Services
9.5.4. Recent Developments
9.6. PGT Healthcare
9.6.1. Company Overview
9.6.2. Financials
9.6.3. Products and Services
9.6.4. Recent Developments
9.7. Takeda Pharmaceutical Company
9.7.1. Company Overview
9.7.2. Financials
9.7.3. Products and Services
9.7.4. Recent Developments
